# Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission

> **NCT00646126** · PHASE3 · COMPLETED · sponsor: **Tropical Medicine Research Institute**

## Conditions studied

- Plasmodium Falciparum
- Asymptomatic Parataemia
- Sub Patent Parasitaemia

## Interventions

- **DRUG:** Sulfadoxine / Pyrimethamine (SP) plus artesunate (AS)
- **DRUG:** placebo tablet similar to active drug in shape and size

## Key facts

- **NCT ID:** NCT00646126
- **Lead sponsor:** Tropical Medicine Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-03-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646126, "Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00646126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*